Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. - Wikidata - wikimedia - TriplyDB

Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.

Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.

http://www.wikidata.org/entity/Q43783358

about

Haloperidol for long-term aggression in psychosis Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation)Risperidone versus other atypical antipsychotics for schizophrenia Clozapine versus other atypical antipsychotics for schizophrenia Olanzapine versus other atypical antipsychotics for schizophrenia Olanzapine for schizophrenia Risperidone versus olanzapine for schizophrenia The schizophrenia phenotype in 22q11 deletion syndrome Clozapine: an effective treatment for seriously violent and psychopathic men with antisocial personality disorder in a UK high-security hospital Mice lacking the immediate early gene Egr3 respond to the anti-aggressive effects of clozapine yet are relatively resistant to its sedating effects.The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder.Pathways to aggression in schizophrenia affect results of treatment Quantifying clinical relevance in the treatment of schizophrenia.Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder.The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.Proximal Risk Factors for Short-Term Community Violence Among Adults With Mental Illnesses.Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidone Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.Effects of paliperidone extended release on hostility among Thai patients with schizophrenia.Representation of people with intellectual disabilities in randomised controlled trials on antipsychotic treatment for behavioural problems.The pharmacological management of violence in schizophrenia: a structured review.Antipsychotic polypharmacy in schizophrenia: benefits and risks.Pharmacological management of acute and persistent aggression in forensic psychiatry settings.A systematic review of the evidence of clozapine's anti-aggressive effects.Clozapine for the treatment of schizophrenia.The psychopharmacology of violence: making sensible decisions.Clozapine use reduced psychiatric hospitalization and emergency room visits in patients with bipolar disorder independent of improved treatment regularity in a three-year follow-up period.Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).Asenapine for the Control of Physical Aggression: A Prospective Naturalist Pilot Study Haloperidol for long-term aggression in psychosis.Leading indicators of community-based violent events among adults with mental illness.Measurement of agitation and aggression in adult and aged neuropsychiatric patients: review of definitions and frequently used measurement scales.Clozapine in Reducing Aggression and Violence in Forensic Populations.Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.Clozapine: a distinct, poorly understood and under-used molecule.Current status of clozapine in the United States.[Pharmacological treatment of impulsivity and aggressive behavior].

P2860

Q24198874-2BC0D98D-846C-4DA7-848B-132AA9325C8A Q24203034-CA9A5BBA-3CBB-4C90-A268-8C273DA532B2 Q24234950-A318A584-0B60-47A0-A0C4-8143A0130918 Q24236422-C4594C44-986B-49AA-85D7-9C9BCB83F13B Q24236545-4F906643-A12D-4394-AA64-68289131D48B Q24244031-0038A939-AE00-4E78-9BA9-DA7A056F9724 Q24246232-1DEBC752-32BA-4F5F-9778-795C11314639 Q24633796-9260DA87-7EDA-48F9-A9F0-C83E7D0FFA4F Q28237349-0590F076-9D64-4CAF-A5E6-08A066B9A96A Q30670738-72ECF993-0A45-4ED1-B6E9-AAC8032A47A2 Q33566124-3B666A1E-77B9-4832-9C82-E6320E3B71F3 Q33826250-013EEF17-83E9-43C3-8284-93C5873F7F9B Q34274859-8AB97318-6516-4991-B0BE-DE96967C357D Q34335555-AEE1E29F-1D8E-4EC5-970C-3EBD8F170782 Q35177162-2AC565D4-6CF5-417B-B55C-BFFD92CD452C Q35819467-3E4D902E-CCEF-426E-8BC0-B67A5B6F2F45 Q35914906-4232D663-9C27-43F8-8CAC-9067AFC953C8 Q35930948-BDB68550-DB92-4316-8BF3-AC1949CB74C8 Q37059146-D2DDB452-2B50-4E79-BF0D-2620757919C0 Q37091444-8CFFFDEF-C999-4600-9443-3920594316D6 Q37532575-B5B3F4EC-2B5D-4DF7-9789-551E47FC1F9F Q37588021-7053D5A3-D96F-4E94-848D-2CB8DD3F6DD1 Q37820701-08C198F0-813F-4A34-B716-70FB5D3E2B55 Q37820986-E4D81178-629F-4C68-9819-4C9E1B81D3C5 Q37863093-676AD184-782C-48FE-B0A2-C36BFDDB6733 Q37963568-05F56B7D-FC95-4006-84A5-5EF49B5E54EE Q37984684-652DE2E4-A3AF-4766-983F-B171130BFF72 Q38026886-41509AB4-97E7-4C23-9FA7-BE382B27AD22 Q38191300-E031FC56-055A-4492-AEB1-29A3B1E2A07F Q38258128-3F713537-4469-4D9D-B836-3D31C42CF7C3 Q38652475-9F126872-2A8B-4E6D-8EE6-0EC306D3ECCB Q38990924-134C6F07-6B88-4CE0-B7B0-94E225C1E1F2 Q39021131-E4515461-0ADE-4E59-AA6A-527E75BF125B Q39081911-10BC1230-8691-4712-BD48-F1B4C5B087E0 Q39126844-9900FC75-C8EC-42BF-B0B2-5812230B227F Q39393088-F02DC935-823B-4BFC-9C0A-E01FE44445EA Q41078160-2A598B1E-6FB0-4DE2-A4B8-65D2F50317C0 Q42807652-9FF0F6AF-6EF0-41BC-A253-72E39F563CCD Q42946206-7C6E5E2A-1DFF-40DE-8319-4A549663A6E9 Q43228395-8A3E71DB-864F-4AAD-BE7F-C628B61D22C4

P2860

Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.

http://www.wikidata.org/entity/Q43783358

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Effects of clozapine, olanzapi ...... g patients with schizophrenia.

@en

Effects of clozapine, olanzapi ...... g patients with schizophrenia.

@nl

type

label

Effects of clozapine, olanzapi ...... g patients with schizophrenia.

@en

Effects of clozapine, olanzapi ...... g patients with schizophrenia.

@nl

prefLabel

Effects of clozapine, olanzapi ...... g patients with schizophrenia.

@en

Effects of clozapine, olanzapi ...... g patients with schizophrenia.

@nl

P1433

Q43783358-A89FD8D0-B8E2-43B4-9714-49F91FA87D5D

P1476

Q43783358-26D920DA-9AD4-449A-9BFA-6A0F63E1032A

P2093

Q43783358-18180888-EE4B-4DEC-9B9E-7CE1327225E3

Q43783358-3D3E9540-ED54-4BD1-94EC-1A597AA59B0D

Q43783358-565B738E-9F96-4B72-9E98-258A63CE542F

Q43783358-5AB3EC80-37D9-467B-8022-E6A0D2D558F1

Q43783358-C57DB2A6-7342-4155-B1AF-F330A854B805

Q43783358-E1A9B1CE-16AB-413A-A136-5376688AB61F

Q43783358-E94EFC36-361F-4F35-A92F-5E2D7EBB08D9

Q43783358-F3965584-1FE8-4CDF-BC6A-05018A168660

P304

Q43783358-9B06276B-2906-467C-B004-C61DFFC7F0EE

P31

Q43783358-F4B1C960-0109-4B9A-9C46-78BB8F195E8F

P356

Q43783358-D56F18EB-0817-45D2-99CF-DF2146C58FA1

P433

Q43783358-C9092457-FA0B-4BF9-8CA5-3CC7FF89A496

P478

Q43783358-F7C6A98D-25E8-4746-88DC-33FEB981A9B6

P50

Q43783358-F1559D17-499A-4C46-9713-EFC7483A363D

P577

Q43783358-F56DBF06-8986-4B13-B27A-DA44C2319958

P5875

Q43783358-EF82FB1E-4807-44C4-A3AD-5193D5B27A2A

P698

Q43783358-ED46C761-C163-46B7-877B-6F59F31B7DC6

P921

Q43783358-12234D30-947D-444F-974E-2C87F3AD7201

P356

APPI.PS.52.11.1510

P1433

Psychiatric Services

P1476

Effects of clozapine, olanzapi ...... g patients with schizophrenia.

@en

P2093

B Sheitman

http://www.w3.org/2001/XMLSchema#string

J A Lieberman

http://www.w3.org/2001/XMLSchema#string

J McEvoy

http://www.w3.org/2001/XMLSchema#string

J P Lindenmayer

http://www.w3.org/2001/XMLSchema#string

J Volavka

http://www.w3.org/2001/XMLSchema#string

M Chakos

http://www.w3.org/2001/XMLSchema#string

P Czobor

http://www.w3.org/2001/XMLSchema#string

T B Cooper

http://www.w3.org/2001/XMLSchema#string

P304

1510-1514

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/APPI.PS.52.11.1510

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11667898

http://www.w3.org/2001/XMLSchema#string

P698

11684748

http://www.w3.org/2001/XMLSchema#string

P921